Top

Neurological Sciences

Published in:

01-08-2018 | Original Article

Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease

Authors: Tamer Yazar, Hülya Olgun Yazar, Emel Zayimoğlu, Soner Çankaya

Published in: Neurological Sciences | Issue 8/2018

Abstract

Aim

In this study, the aim was to identify the incidence of sarcopenia and dynapenia according to disease stage among idiopathic Parkinson’s disease (IPD) patients and collect data to illuminate precautions related to reducing the disease load.

Method

The study was completed with 166 patients divided by stage according to modified Hoehn and Yahr (HYR) criteria and 249 healthy volunteers aged from 18 to 39 and 68 to 75 years met the inclusion criteria. In our prospective and cross-sectional study, patients with IPD according to “UK Brain Bank” diagnostic criteria had the Unified Parkinson’s Disease Rating Scale (UPDRS) and HYR scales applied. The patient and control groups had skeletal muscle mass index (SMMI), muscle power, and physical performance assessed. Diagnosis of sarcopenia used the European Working Group on Sarcopenia in Older People (EWGSOP) diagnostic criteria.

Results

In our study, in parallel with the increase in disease stage among IPD patients, the incidence of sarcopenia (led by severe sarcopenia) and dynapenia was high compared to that among the control group of the same age.

Conclusion

In the early stages of chronic progressive diseases like IPD, identification of sarcopenia and dynapenia is important considering the limitations of disease-preventive effects in treatments applied after diagnosis.

Torun Ş, Uysal M, Gücüyener D, Özdemir G (1995) Parkinson’s disease in Eskişehir, Turkey. Eur J Neurol 2:44–45

Xu XM, Dong MX, Feng X, Liu Y, Pan JX, Jia SY, Cao D, Wei YD (2018) Decreased serum proNGF concentration in patients with Parkinson’s disease. Neurol Sci Jan 39:91–96CrossRef

Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S–991SCrossRefPubMed

Rosenberg I (1989) Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50:1231–1233CrossRef

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763CrossRefPubMed

Rosenberg IH, Roubenoff R (1995) Stalking sarcopenia. Ann Intern Med 123(9):727–728CrossRefPubMed

Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men Research Group (2007) Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 55(8):1216–1223CrossRefPubMed

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423CrossRefPubMedCentralPubMed

Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB, Health ABC Study Investigators (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51(11):1602–1609CrossRefPubMed

10.

Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB, for the Health ABC Study (2006) The loss of skeletal muscle strength, mass and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064CrossRefPubMed

11.

Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S (2016) The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 71:259–264CrossRefPubMed

12.

Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E (2016) Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 17(7):640–646CrossRefPubMed

13.

Yürüyen M, Yavuzer H, Yavuzer S, Cengiz M, Demirdağ F, Kara Z et al (2017) Comparison of nutritional risk screening tools for predicting sarcopenia in hospitalized patients. Turk J Med Sci 47:1362–1369CrossRef

14.

Yadigar S, Yavuzer H, Yavuzer S, Cengiz M, Yürüyen M, Döventaş A et al (2017) Primary sarcopenia in older people with normal nutrition. J Nutr Health Aging 21(8):849–854CrossRef

15.

Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13(1):1–7CrossRefPubMed

16.

Morley JE (2008) Sarcopenia: diagnosis and treatment. J Nutr Health Aging 12(7):452–456CrossRefPubMed

17.

Janssen I (2011) The epidemiology of sarcopenia. Clin Geriatr Med 27(3):355–363CrossRefPubMed

18.

Wang C, Bai L (2012) Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int 12(3):388–396CrossRefPubMed

19.

Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR (2008) Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr 87(5):1562S–1566SCrossRefPubMed

20.

Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368–376CrossRefPubMed

21.

Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 17:867–876CrossRefPubMed

22.

Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRefPubMed

23.

Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (1985) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003 95(5):1851–1860CrossRef

24.

Trojano L, Papagno C (2018) Cognitive and behavioral disorders in Parkinson’s disease: an update. II: behavioral disorders. Neurol Sci 39(1):53–61CrossRefPubMed

25.

Gazibara T, Kisic-Tepavcevic D, Svetel M, Tomic A, Stankoviç İ, Kostic V, Pekmezovic T (2017) Dynamics of change in self-reported disability among persons with Parkinson’s disease after 2 years of follow-up. Neurol Sci 38:1415–1421CrossRefPubMed

26.

Morley JE (2002) Pathophysiology of anorexia. Clin Geriatr Med 18:661–663CrossRefPubMed

27.

Seiler WO (2001) Clinical pictures of malnutrition in ill elderly subjects. Nutrition 17(6):496–498CrossRefPubMed

28.

Saji N, Arai H, Sakurai T, Toba K (2016) Frailty and sarcopenia: a new bridge to dementia. Nihon Rinsho 74(3):505–509PubMed

29.

Bahat G, Tufan A, Tufan F, Kılıc C, Akpinar S, Kose M (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 2(6):35

30.

Kim H, Hirano H, Edahiro A, Ohara Y, Watanebe Y, Kojima N, Kim M, Hosoi E, Yoshida Y, Yoshida H, Shinkai S (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16(Suppl 1):110–122CrossRefPubMed

31.

Bahat G, Tufan A, Tufan F, Karan MA (2017) Significance of population differences and the methodology in determining the muscle mass cut-off points for sarcopenia. Geriatr Gerontol Int 17(3):521–522CrossRefPubMed

32.

Van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 18(3):263–267CrossRefPubMed

33.

Davide L, Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V et al (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc S1525-8610(17):30683–30687

34.

Drey M, Hassman SE, Krenovsky JP, Hobert MA, Straub S, Elshehabi M et al (2017) Associations between early markers of Parkinson’s disease and sarcopenia. Front Aging Neurosci 9:53 eCollection 2017CrossRefPubMedCentralPubMed

35.

Tolea MI, Galvin JE (2015) Sarcopenia and impairment in cognitive and physical performance. Clin İnterv Aging 10:663–671CrossRefPubMedCentralPubMed

36.

Lee YS, Kim SD, Kang HJ, Kim SW, Shin IS, Yoon JS, Kim JM (2017) Associations of upper arm and thigh circumferences with dementia and depression in Korean elders. Psychiatry Investig 14(2):150–157CrossRefPubMedCentralPubMed

Title: Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease
Authors: Tamer Yazar
Hülya Olgun Yazar
Emel Zayimoğlu
Soner Çankaya
Publication date: 01-08-2018
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 8/2018
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-018-3439-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson’s disease

Abstract

Aim

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aim

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2018

Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study

Cognitive assessment in multiple sclerosis—an Italian consensus

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients

Coping strategies in caregivers of disorders of consciousness patients

Psychometric properties of the Italian version of the Cognitive Reserve Scale (I-CRS)